PMID- 23870824 OWN - NLM STAT- MEDLINE DCOM- 20140422 LR - 20130920 IS - 1878-3279 (Electronic) IS - 0171-2985 (Linking) VI - 218 IP - 11 DP - 2013 Nov TI - Monocyte-derived dendritic cell subpopulations use different types of matrix metalloproteinases inhibited by GM6001. PG - 1361-9 LID - S0171-2985(13)00125-3 [pii] LID - 10.1016/j.imbio.2013.06.012 [doi] AB - Matrix metalloproteinases (MMPs) are endopeptidases with the potential to cleave extracellular matrix, support tissue renewal and regulate cell migration. Functional activities of MMPs are regulated by tissue inhibitors of MMPs (TIMPs) and disruption of the MMP-TIMP balance has pathological consequences. Here we studied the expression and secretion of MMPs and TIMPs in CD1a(-) and CD1a(+) monocyte-derived dendritic cell (DC) subpopulations. Our results showed that monocytes express TIMPs but lack MMPs, whereas upon differentiation to moDCs and in response to activation signals the expression of MMPs is increased and that of TIMPs is decreased. MMP-9 is expressed dominantly in the CD1a(-) subpopulation, while MMP-12 is preferentially expressed in CD1a(+) cells. Experiments performed with the synthetic MMP inhibitor GM6001 revealed that this drug efficiently inhibits the migration of moDCs through inactivation of MMPs. We conclude that modulation of MMP activity by GM6001 emerges as a novel approach to manipulate DC migration under inflammatory conditions. CI - Copyright (c) 2013 Elsevier GmbH. All rights reserved. FAU - Kis-Toth, Katalin AU - Kis-Toth K AD - Department of Immunology, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary; Department of Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, USA. Electronic address: katakt@gmail.com. FAU - Bacskai, Ildiko AU - Bacskai I FAU - Gogolak, Peter AU - Gogolak P FAU - Mazlo, Anett AU - Mazlo A FAU - Szatmari, Istvan AU - Szatmari I FAU - Rajnavolgyi, Eva AU - Rajnavolgyi E LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130702 PL - Netherlands TA - Immunobiology JT - Immunobiology JID - 8002742 RN - 0 (Antigens, CD1) RN - 0 (CD1a antigen) RN - 0 (Dipeptides) RN - 0 (Matrix Metalloproteinase Inhibitors) RN - 0 (N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide) RN - 0 (TIMP1 protein, human) RN - 0 (TIMP2 protein, human) RN - 0 (Tissue Inhibitor of Metalloproteinase-1) RN - 127497-59-0 (Tissue Inhibitor of Metalloproteinase-2) RN - EC 3.4.24.35 (MMP9 protein, human) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) RN - EC 3.4.24.65 (MMP12 protein, human) RN - EC 3.4.24.65 (Matrix Metalloproteinase 12) SB - IM MH - Antigens, CD1/metabolism MH - Cell Differentiation/immunology MH - Cell Movement/*drug effects/immunology MH - Cells, Cultured MH - Dendritic Cells/*immunology MH - Dipeptides/*pharmacology MH - Humans MH - Inflammation/*immunology MH - Matrix Metalloproteinase 12/biosynthesis/metabolism MH - Matrix Metalloproteinase 9/biosynthesis/metabolism MH - Matrix Metalloproteinase Inhibitors/*pharmacology MH - Monocytes MH - Tissue Inhibitor of Metalloproteinase-1/biosynthesis/metabolism MH - Tissue Inhibitor of Metalloproteinase-2/biosynthesis/metabolism OTO - NOTNLM OT - CD1a OT - DC OT - Dendritic cell OT - IDC OT - Immunotherapy OT - LCH OT - LPS OT - Langerhans cell histiocytosis OT - MDC OT - MMP OT - Matrix metalloproteinase OT - TIMP OT - Tissue inhibitor of matrix metalloproteinase OT - dendritic cell OT - immature DC OT - lipopolysaccharide OT - matrix metalloproteinase OT - mature DC OT - tissue inhibitor of matrix metalloproteinase EDAT- 2013/07/23 06:00 MHDA- 2014/04/23 06:00 CRDT- 2013/07/23 06:00 PHST- 2013/03/11 00:00 [received] PHST- 2013/06/19 00:00 [revised] PHST- 2013/06/24 00:00 [accepted] PHST- 2013/07/23 06:00 [entrez] PHST- 2013/07/23 06:00 [pubmed] PHST- 2014/04/23 06:00 [medline] AID - S0171-2985(13)00125-3 [pii] AID - 10.1016/j.imbio.2013.06.012 [doi] PST - ppublish SO - Immunobiology. 2013 Nov;218(11):1361-9. doi: 10.1016/j.imbio.2013.06.012. Epub 2013 Jul 2.